RECRUITING

External Pharyngeal Exerciser and Pharyngeal Phase of Swallowing

Talk to us

Conditions

Dysphagia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study of healthy young and elderly individuals is intended to assess the effects of pharyngeal exerciser on pharyngeal pressure phenomenon during swallowing. Our specific aim is to test if the pharyngeal exerciser increases the workload of muscles involved in pharyngeal phase of swallowing.

Official Title

Impact of External Pharyngeal Exerciser on Pharyngeal Phase of Swallowing

Quick Facts

Study Start:2014-09-16
Study Completion:2024-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05708911

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Healthy volunteers must be at least 18 years of age or older.
  1. * Subjects with cervical spine disorders.
  2. * Subjects with neurological disorders like dementia, cerebrovascular diseases other than Parkinson's Disease
  3. * Subjects with carotid artery bruit or carotid vascular disorders.
  4. * Subjects suffering from muscle diseases like muscular dystrophies, myopathies.
  5. * Subjects with neuro-muscular junction disorders myasthenia gravis, Eaton-Lambert disorders.
  6. * Subjects with any current esophageal symptoms like heartburn, dysphagia, chest pain or regurgitation.
  7. * Subjects cannot have previous head or neck surgery or radiation.
  8. * Subjects unable to tolerate nasal intubation.
  9. * Subjects with significant bleeding disorders for whom nasal intubation has been deemed contraindicated.
  10. * Subjects with a known upper airway or esophageal obstruction preventing the passage of the manometry probe.
  11. * Subjects with autonomic dysfunction.
  12. * Subjects having a history of allergy to lidocaine and barium.
  13. * Subjects who are pregnant or lactating.
  14. * Subjects who have advanced medical disorders (e.g.: chronic obstructive pulmonary disease (COPD), congestive heart failure, cirrhosis, cancer, chronic renal failure, etc.).
  15. * Subjects who are medically unstable.

Contacts and Locations

Study Contact

Reza Shaker, MD
CONTACT
4149556840
rshaker@mcw.edu
Mark Kern
CONTACT
4148053826
mkern@mcw.edu

Principal Investigator

Reza Shaker, MD
PRINCIPAL_INVESTIGATOR
Medical College of Wisconsin

Study Locations (Sites)

Medical College of Wisconsin
Milwaukee, Wisconsin, 53086
United States

Collaborators and Investigators

Sponsor: Medical College of Wisconsin

  • Reza Shaker, MD, PRINCIPAL_INVESTIGATOR, Medical College of Wisconsin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2014-09-16
Study Completion Date2024-09-30

Study Record Updates

Study Start Date2014-09-16
Study Completion Date2024-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Dysphagia